SEARCH

SEARCH BY CITATION

References

  • Ahn K., Shelton C. C., Tian Y., Zhang X., Gilchrist M. L., Sisodia S. S. and Li Y. M. (2010) Activation and intrinsic gamma-secretase activity of presenilin 1. Proc. Natl Acad. Sci. USA 107, 2143521440.
  • Beher D., Wrigley J. D., Owens A. P. and Shearman M. S. (2002) Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activity. J. Neurochem. 82, 563575.
  • Beher D., Clarke E. E., Wrigley J. D., Martin A. C., Nadin A., Churcher I. and Shearman M. S. (2004) Selected non-steroidal anti-inflammatory drugs and their derivatives target gamma-secretase at a novel site. Evidence for an allosteric mechanism. J. Biol. Chem. 279, 4341943426.
  • Borgegard T., Jureus A., Olsson F. et al. (2012) First and second generation gamma-secretase modulators (GSMs) modulate amyloid-beta (Abeta) peptide production through different mechanisms. J. Biol. Chem. 287, 1181011819.
  • De S. B., Annaert W., Cupers P. et al. (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398, 518522.
  • Dyrks T., Dyrks E., Masters C. and Beyreuther K. (1992) Membrane inserted APP fragments containing the beta A4 sequence of Alzheimer's disease do not aggregate. FEBS Lett. 309, 2024.
  • Ebke A., Luebbers T., Fukumori A., Shirotani K., Haass C., Baumann K. and Steiner H. (2011) Novel gamma-secretase enzyme modulators directly target presenilin protein. J. Biol. Chem. 286, 3718137186.
  • Edbauer D., Winkler E., Regula J. T., Pesold B., Steiner H. and Haass C. (2003) Reconstitution of gamma-secretase activity. Nat. Cell Biol. 5, 486488.
  • Esler W. P., Kimberly W. T., Ostaszewski B. L., Diehl T. S., Moore C. L., Tsai J. Y., Rahmati T., Xia W., Selkoe D. J. and Wolfe M. S. (2000) Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1. Nat. Cell Biol. 2, 428434.
  • Francis R., McGrath G., Zhang J. et al. (2002) aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev. Cell 3, 8597.
  • Glenner G. G. and Wong C. W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885890.
  • Goutte C., Tsunozaki M., Hale V. A. and Priess J. R. (2002) APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos. Proc. Natl Acad. Sci. USA 99, 775779.
  • Kimberly W. T., LaVoie M. J., Ostaszewski B. L., Ye W., Wolfe M. S. and Selkoe D. J. (2003) Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc. Natl Acad. Sci. USA 100, 63826387.
  • Kukar T. L., Ladd T. B., Bann M. A. et al. (2008) Substrate-targeting gamma-secretase modulators. Nature 453, 925929.
  • Kukar T. L., Ladd T. B., Robertson P. et al. (2011) Lysine 624 of the amyloid precursor protein (APP) is a critical determinant of amyloid beta peptide length: support for a sequential model of gamma-secretase intramembrane proteolysis and regulation by the amyloid beta precursor protein (APP) juxtamembrane region. J. Biol. Chem. 286, 3980439812.
  • Li Y. M., Xu M., Lai M. T. et al. (2000) Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 405, 689694.
  • Lichtenthaler S. F., Ida N., Multhaup G., Masters C. L. and Beyreuther K. (1997) Mutations in the transmembrane domain of APP altering gamma-secretase specificity. Biochemistry 36, 1539615403.
  • Lichtenthaler S. F., Multhaup G., Masters C. L. and Beyreuther K. (1999a) A novel substrate for analyzing Alzheimer's disease gamma-secretase. FEBS Lett. 453, 288292.
  • Lichtenthaler S. F., Wang R., Grimm H., Uljon S. N., Masters C. L. and Beyreuther K. (1999b) Mechanism of the cleavage specificity of Alzheimer's disease gamma-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein. Proc. Natl Acad. Sci. USA 96, 30533058.
  • Lichtenthaler S. F., Beher D., Grimm H. S., Wang R., Shearman M. S., Masters C. L. and Beyreuther K. (2002) The intramembrane cleavage site of the amyloid precursor protein depends on the length of its transmembrane domain. Proc. Natl Acad. Sci. USA 99, 13651370.
  • Lleo A., Berezovska O., Herl L., Raju S., Deng A., Bacskai B. J., Frosch M. P., Irizarry M. and Hyman B. T. (2004) Nonsteroidal anti-inflammatory drugs lower Abeta42 and change presenilin 1 conformation. Nat. Med. 10, 10651066.
  • Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L. and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl Acad. Sci. USA 82, 42454249.
  • Munter L. M., Voigt P., Harmeier A., Kaden D., Gottschalk K. E., Weise C., Pipkorn R., Schaefer M., Langosch D. and Multhaup G. (2007) GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42. EMBO J. 26, 17021712.
  • Murphy M. P., Hickman L. J., Eckman C. B., Uljon S. N., Wang R. and Golde T. E. (1999) gamma-Secretase, evidence for multiple proteolytic activities and influence of membrane positioning of substrate on generation of amyloid beta peptides of varying length. J. Biol. Chem. 274, 1191411923.
  • Narlawar R., Baumann K., Czech C. and Schmidt B. (2007) Conversion of the LXR-agonist TO-901317–from inverse to normal modulation of gamma-secretase by addition of a carboxylic acid and a lipophilic anchor. Bioorg. Med. Chem. Lett. 17, 54285431.
  • Ohki Y., Higo T., Uemura K., Shimada N., Osawa S., Berezovska O., Yokoshima S., Fukuyama T., Tomita T. and Iwatsubo T. (2011) Phenylpiperidine-type gamma-secretase modulators target the transmembrane domain 1 of presenilin 1. EMBO J. 30, 48154824.
  • Page R. M., Gutsmiedl A., Fukumori A., Winkler E., Haass C. and Steiner H. (2010) Beta-amyloid precursor protein mutants respond to gamma-secretase modulators. J. Biol. Chem. 285, 1779817810.
  • Qi-Takahara Y., Morishima-Kawashima M., Tanimura Y. et al. (2005) Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase. J. Neurosci. 25, 436445.
  • Quintero-Monzon O., Martin M. M., Fernandez M. A., Cappello C. A., Krzysiak A. J., Osenkowski P. and Wolfe M. S. (2011) Dissociation between the processivity and total activity of gamma-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations. Biochemistry 50, 90239035.
  • Ren Z., Schenk D., Basi G. S. and Shapiro I. P. (2007) Amyloid beta-protein precursor juxtamembrane domain regulates specificity of gamma-secretase-dependent cleavages. J. Biol. Chem. 282, 3535035360.
  • Sagi S. A., Lessard C. B., Winden K. D., Maruyama H., Koo J. C., Weggen S., Kukar T. L., Golde T. E. and Koo E. H. (2011) Substrate sequence influences gamma-secretase modulator activity, role of the transmembrane domain of the amyloid precursor protein. J. Biol. Chem. 286, 3979439803.
  • Sato T., Tang T. C., Reubins G., Fei J. Z., Fujimoto T., Kienlen-Campard P., Constantinescu S. N., Octave J. N., Aimoto S. and Smith S. O. (2009) A helix-to-coil transition at the epsilon-cut site in the transmembrane dimer of the amyloid precursor protein is required for proteolysis. Proc. Natl Acad. Sci. USA 106, 14211426.
  • Seiffert D., Bradley J. D., Rominger C. M. et al. (2000) Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitors. J. Biol. Chem. 275, 3408634091.
  • Takami M., Nagashima Y., Sano Y., Ishihara S., Morishima-Kawashima M., Funamoto S. and Ihara Y. (2009) gamma-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. J. Neurosci. 29, 1304213052.
  • Takasugi N., Tomita T., Hayashi I., Tsuruoka M., Niimura M., Takahashi Y., Thinakaran G. and Iwatsubo T. (2003) The role of presenilin cofactors in the gamma-secretase complex. Nature 422, 438441.
  • Theuns J., Marjaux E., Vandenbulcke M., Van L. K., Kumar-Singh S., Bormans G., Brouwers N., Van den B. and M., Vennekens K., Corsmit E., Cruts M., De S. B., Van B. C. and Vandenberghe R. (2006) Alzheimer dementia caused by a novel mutation located in the APP C-terminal intracytosolic fragment. Hum. Mutat. 27, 888896.
  • Uemura K., Farner K. C., Hashimoto T., Nasser-Ghodsi N., Wolfe M. S., Koo E. H., Hyman B. T. and Berezovska O. (2010) Substrate docking to gamma-secretase allows access of gamma-secretase modulators to an allosteric site. Nat. Commun. 1, 130.
  • Weggen S. and Beher D. (2012) Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease. Alzheimers Res. Ther. 4, 9.
  • Wolfe M. S., Xia W., Ostaszewski B. L., Diehl T. S., Kimberly W. T. and Selkoe D. J. (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398, 513517.
  • Wrigley J. D., Schurov I., Nunn E. J., Martin A. C., Clarke E. E., Ellis S., Bonnert T. P., Shearman M. S. and Beher D. (2005) Functional overexpression of gamma-secretase reveals protease-independent trafficking functions and a critical role of lipids for protease activity. J. Biol. Chem. 280, 1252312535.
  • Yu G., Nishimura M., Arawaka S. et al. (2000) Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature 407, 4854.
  • Zhang J., Ye W., Wang R., Wolfe M. S., Greenberg B. D. and Selkoe D. J. (2002) Proteolysis of chimeric beta-amyloid precursor proteins containing the Notch transmembrane domain yields amyloid beta-like peptides. J. Biol. Chem. 277, 1506915075.